Journal of Affective Disorders
Volume 85, Issue 3 , Pages 301-315 , April 2005

Prevalence and distinct correlates of anxiety, substance, and combined comorbidity in a multi-site public sector sample with bipolar disorder

  • Mark S. Bauer

      Affiliations

    • VAMC and Brown University, 116R, 830 Chalkstone Avenue, Providence, RI 02908-4799, United States
    • Corresponding Author InformationCorresponding author. Tel.: +1 401 273 7100x3863; fax: +1 401 457 3311.
  • ,
  • Lori Altshuler

      Affiliations

    • West LA VAMC and UCLA, Los Angeles, CA, United States
  • ,
  • Denise R. Evans

      Affiliations

    • Augusta VAMC and Medical College of Georgia, Augusta, GA, United States
  • ,
  • Thomas Beresford

      Affiliations

    • Denver VAMC and University of Colorado, Denver, CO, United States
  • ,
  • William O. Williford

      Affiliations

    • Perry Point VAMC and University of Maryland, Perry Point, MD, United States
  • ,
  • Richard Hauger

      Affiliations

    • San Diego VAMC and UCSD, San Diego, CA, United States
  • ,
  • for the VA Cooperative Study #430 Team

Received 12 April 2004 ,Accepted 30 November 2004.

References 

  1. American Psychiatric Association (APA) . Diagnostic and statistical manual of mental disorders. 4th edition. Washington, DC: American Psychiatric Association; 1994;text revision
  2. Anand A, Verhoeff P, et al. Brain SPECT imaging of amphetamine-induced dopamine release in euthymic bipolar disorder patients. Am. J. Psychiatry. 2000;157:1108–1114
  3. Barrett TB, Hauger RL, Kennedy JL, Sadovnick AD, Remick RA, Keck PE, et al. Evidence that a single nucleotide polymorphism in the promoter of the G protein receptor kinase 3 gene is associated with bipolar disorder. Mol. Psychiatry. 2003;8:546–557
  4. Bauer M. The collaborative practice model in bipolar disorder: design and implementation in a multi-site randomized controlled trial. Bipolar Disord. 2001;3:233–244
  5. Bauer M, Williford W, Dawson E, Akiskal H, Altshuler L, Fye C, et al. Principles of effectiveness trials and their implementation in VA Cooperative Study #430, “reducing the efficacy-effectiveness gap in bipolar disorder”. J. Affect Disord. 2001;67:61–78
  6. Bernadt MW, Murray RM. Psychiatric disorder, drinking and alcoholism. Br. J. Psychiatry. 1986;148:393–400
  7. Brady K, Castro S. Substance abuse in an inpatient psychiatric sample. Am. J. Drug Alcohol Abuse. 1991;17:389–397
  8. Cassidy F, Ahearn EP, Carroll BJ. Substance abuse in bipolar disorder. Bipolar Disord. 2001;3:181–188
  9. Craig T, Hwang MY, Bromet EJ. Obsessive–compulsive and panic symptoms in patients with first-admission psychosis. Am. J. Psychiatry. 2002;159:592–598
  10. Dautzenberg FM, Hauger RL. The CRF peptide family and their receptors: yet more partners discovered. Pharmacol. Sci. 2002;23:71–77
  11. Dilsaver SC, Chen YW. Suicidality, panic disorder and psychosis in bipolar depression, depressive-mania and pure-mania. Psychiatry Res. 1997;73:47–56
  12. Dilsaver SC, Chen YW. Social phobia, panic disorder and suicidality in subjects with pure and depressive mania. J. Affect Disord. 2003;77:173–177
  13. D'Mello DA, Boltz MK, Msibi B. Relationship between concurrent substance abuse in psychiatric patients and neuroleptic dosage. Am. J. Drug Alcohol Abuse. 1995;21:257–265
  14. Doughty CJ, Wells JE, Joyce PR, Olds RJ, Walsh AES. Bipolar-panic disorder comorbidity within bipolar disorder families: a study of siblings. Bipolar Disord. 2004;6:245–252
  15. Estroff TW, Dackis CA, Gold MS, Pottash ALC. Drug abuse and bipolar disorders. Int. J. Psychiatry Med. 1985;15:37–40
  16. Feinman JA, Dunner DL. The effect of alcohol and substance abuse on the course of bipolar affective disorder. J. Affect Disord. 1996;37:43–49
  17. Feske U, Frank E, Mallinger AG, Houck PR, Fagiolini A, Shear MK, et al. Anxiety as a correlate of response to the acute treatment of bipolar I disorder. Am. J. Psychiatry. 2000;157:956–962
  18. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured clinical interview for axis I DSM-VI disorders-(SCID) patient edition, version 2.0. New York, NY: Biometrics Research Department, New York Psychiatric Institute; 1996;
  19. Fogel B, Bauer MS, Kendall S, Holden F. Psychiatric comorbidities and hospitalization for mania. Biol. Psychiatry. 1994;35:412A
  20. Folstein M, Folstein S, McHugh P. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975;12:189–198
  21. Frank E, Cyranowski JM, Rucci P, Shear MK, Fagiolini A, Thase ME, et al. Clinical significance of lifetime panic spectrum symptoms in the treatment of patients with bipolar I disorder. Arch. Gen. Psychiatry. 2002;59:905–911
  22. Freed EX. Alcohol abuse by manic patients. Psychol. Rep. 1969;25:280
  23. Frye MA, Altshuler LL, McElroy SL, Suppes T, Keck PE, Denicoff K, et al. Gender differences in prevalence, risk, and clinical correlates for alcoholism comorbidity in bipolar disorder. Am. J. Psychiatry. 2003;160:883–888
  24. Goodwin RD, Hoven CW. Bipolar-panic comorbidity in the general population: prevalence and associated morbidity. J. Affect. Disord. 2002;70:27–33
  25. Goodwin FK, Jamison KR. Alcohol and drug abuse in manic–depressive illness. Manic–depressive illness. Oxford University Press; 1990;
  26. Goodwin RD, Stayner DA, Chinman MJ, Wu P, Tebes J, Davidson L. The relationship between anxiety and substance use disorders among individuals with severe affective disorders. Comp. Psychiatry. 2002;43:245–252
  27. Heinz A. Dopaminergic dysfunction in alcoholism and schizophrenia—psychopathological and behavioral correlates. Eur. Psychiatry: J. Assoc. Eur. Psychiatr. 2002;17:9–16
  28. Heinz A, Lichtenberg-Kraag B, Baum SS, Graf K, Kruger F, Dettling M, et al. Evidence for prolonged recovery of dopaminergic transmission after detoxification in alcoholics with poor treatment outcome. J. Neural Trans-General Section. 1995;102:149–157
  29. Helzer JE, Pryzbeck TR. The co-occurrence of alcoholism with other psychiatric disorders in the general population and its impact on treatment. J. Stud. Alcohol. 1988;49:219–224
  30. Henry C, Van den Bulke D, Bellivier F, Etain B, Rouillon F, Leboyer M. Anxiety disorders in 318 bipolar patients: prevalence and impact on illness severity and response to mood stabilizer. J. Clin. Psychiatry. 2003;64:331–335
  31. Himmelhoch JM, Mulla D, Neil JF, Tetre TP, Kupfer DJ. Incidence and significance of mixed affective states in a bipolar population. Arch. Gen. Psychiatry. 1976;33:1062–1066
  32. Judd LL, Akiskal HS, Schettler PJ, Endicott J, Maser J, Solomon DA, et al. The long-term natural history of the weekly symptomatic status of biopolar I disorder. Arch. Gen. Psychiatry. 2002;59:530–537
  33. Kay JH, Altshuler LL, Ventura J. Prevalence of axis II comorbidity in bipolar patients with and without alcohol use disorders. Ann. Clin. Psychiatry. 1999;11:187–195
  34. Keck PE, McElroy SL, Strakowski SM, West SA, Hawkins JM, Huber TJ, et al. Outcome and comorbidity in first-compared with multiple-episode mania. J. of Nerv. Ment. Dis. 1995;183:320–324
  35. Kennedy BL, Dhaliwal N, Pedley L, Sahner C, Greenberg R, Manshadi MS. Post-traumatic stress disorder in subjects with schizophrenia and bipolar disorder. J. Ky. Med. Assoc. 2002;100:395–399
  36. Kraepelin, E. 1976. Manic Depressive Insanity and Paranoia. Translated by RM Barclay, Edited by GM Robertson. Edinburgh: E & S Livingstone, 1921. Reprinted New York: Arno Press.
  37. Kruger S, Braunig P. Comorbidity of obsessive–compulsive disorder in recovered inpatients with bipolar disorder. Bipolar Disord. 2000;2:71–74
  38. Kruger S, Cooke RG, Hasey GM, Jorna T, Persad E. Comorbidity of obsessive–compulsive disorder in bipolar disorder. J. Affect Disord. 1995;34:117–120
  39. Kusznir A, Cooke RG, Young LT. The correlates of community functioning in patients with bipolar disorder. J. Affect Disord. 2000;61:81–85
  40. Lambert MT, Griffith JM. Characteristics of patients with substance abuse diagnoses on a general psychiatry unit in a VA medical center. Psychiatr. Serv. 1996;47:1104–1107
  41. MacKinnon DF, Zandi PP, Cooper J, Potash JB, Simpson SG, Gershon E, et al. Comorbid bipolar disorder and panic disorder in families with a high prevalence of bipolar disorder. Am. J. Psychiatry. 2002;159:30–35
  42. MacKinnon DF, Zandi PP, Gershon ES, Nurnberger JI, DePaulo JR. Association of rapid mood switching with panic disorder and familial panic risk in familial bipolar disorder. Am. J. Psychiatry. 2003;160:1696–1698
  43. MacKinnon DF, Zandi PP, Gershon ES, Nurnberger JI, Reich T, DePaulo JR. Rapid switching of mood in families with multiple cases of bipolar disorder. Arch. Gen. Psychiatry. 2003;60:921–928
  44. MacQueen GM, Marriott M, Begin H, Robb J, Joffe RT, Young LT. Subsyndronial symptoms assessed in longitudinal, prospective follow-up in a cohort of patients with bipolar disorder. Bipolar Disord. 2003;5:349–355
  45. Marken PA, Stanislav SW, Lacombe S, Pierce C, Horstra R, Sommi RW. Profile of a sample of subjects admitted to an acute care psychiatric facility with manic symptoms. Psychopharmacol. Bull. 1992;28:201–205
  46. McElroy SL, Strakowski SM, West SA, Keck PE, McConville BJ. Phenomenology of adolescent and adult mania in hospitalized patients with bipolar disorder. Am. J. Psychiatry. 1997;1541:44–49
  47. McElroy SL, Altshuler LL, Suppes T, Keck PE, Frye MA, Denicoff KD, et al. Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am. J. Psychiatry. 2001;158:420–426
  48. Mendlewicz J, Fieve RR, Rainer J, Fleiss JL. Manic–depressive illness: a comparative study of patients with and without a family history. Br. J. Psychiatry. 1989;120:523–530
  49. Miller FT, Busch F, Tanenbaum JH. Drub abuse in schizophrenia and bipolar disorder. Am. J. Drug Alcohol Abuse. 1989;15:291–295
  50. Morrison JR. Bipolar affective disorder and alcoholism. Am. J. Psychiatry. 1974;131:1130–1133
  51. Mueser KT, Yarnold PR. Diagnostic and demographic correlates of substance abuse in schizophrenia and major affective disorder. Acta Psychiatr. Scand. 1992;85:48–55
  52. Mueser KT, Trumbetta SL, Rosenberg SD, Vidaver R, Goodman LB, Osher FC, et al. Trauma and posttraumatic stress disorder in severe mental illness. J. Consult. Clin. Psychol. 1998;66:493–499
  53. Nabati L, Shea N, McBride L, Gavin C, Bauer M. Adaptation of a simple patient satisfaction survey to mental health: psychometric properties. Psychiatry Res. 1998;77:51–56
  54. Neria Y, Bromet EJ, Sievers S, Lavelle J, Fochtmann LJ. Trauma exposure and post-traumatic stress disorder in psychosis: findings from a first-admission cohort. J. Consult. Clin. Psychol. 2002;70:246–251
  55. O'Croinin F, Zibin T, Byrne A. Life events and relapse in bipolar disorder (letter). Br. J. Psychiatry. 1994;164:417
  56. Parker JB, Meiller RM, Andrews GW. Major psychiatric disorders masquerading as alcoholism. South Med. J. 1960;53:560–564
  57. Perugi G, Akiskal HS, Toni C. The temporal relationship between anxiety disorders and (hypo)mania: a retrospective examination of 63 panic, social phobic and obsessive–compulsive patients with comorbid bipolar disorder. J. Affect Disord. 2001;67:199–206
  58. Perugi G, Frare F, Madaro D, Maremmani I, Akiskal HS. Alcohol abuse in social phobic patients: is there a biopolar connection?. J. Affect Disord. 2002;68:33–39
  59. Pini S, Cassano GB, Simonini E, Savino M, Russo A, Montgomery SA. Prevalence of anxiety disorders comorbidity in bipolar depression, unipolar depression and dysthymia. J. Affect Disord. 1997;42:145–153
  60. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL. Goodwin FK. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the epidemiologic catchment area (ECA) study. JAMA. 1990;264:2511–2518(comment)
  61. Reich LH, Davies RK, Himmelhoch JM. Excessive alcohol use in manic–depressive illness. Am. J. Psychiatry. 1974;131:83–86
  62. Rihmer Z, Szadoczky E, Furedi J. Anxiety disorders comorbidity in bipolar I bipolar II and unipolar major depression: results from a population-based study in Hungary. J. Affect Disord. 2001;67:175–179
  63. Rodriguez BF, Weisberg RB, Pagano ME, Machan JT, Culpepper L, Keller MB. Frequency and patterns of psychiatric comorbidity in a sample of primary care patients with anxiety disorders. Comp. Psychiatry. 2004;45:129–137
  64. Rotondo A, Mazzanti C, Dell'Osso L, Rucci P, Sullivan P, Bouanani S, et al. Catechol 0-methyltransferase, serotonin transporter, and tryptophan hydroxylase gene polymorphisms in bipolar disorder patients with and without comorbid panic disorder. Am. J. Psychiatry. 2002;159:23–29
  65. Salloum IM, Cornelius JR. Characterizing female bipolar alcoholic patients presenting for initial evaluation. Addict Behav. 2001;26:341–348
  66. Simon NM, Smoller JW, Fava M, Sachs G, Racette SR, Perlis R, et al. Comparing anxiety disorders and anxiety-related traits in bipolar and unipolar depression. J. Psychiatric Res. 2003;37:187–192
  67. Simon NM, Otto MW, Wisniewski SR, Fossey M, Sagduyu K, Frank E, et al. Anxiety disorder comorbidity in bipolar disorder: data from the first 500 STEP-BD participants. Am. J. Psychiatry. 2004;161:2222–2229
  68. Sonne SC, Brady KT. Substance abuse and bipolar comorbidity. Psychiatr. Clin. North Am. 1999;22:609–627
  69. Sonne SC, Brady KT, Morton WA. Substance abuse and bipolar affective disorder. J. Nerv. Ment. Dis. 1994;182:349–352
  70. Stewart A, Hays R, Ware J. The MOS short-form general health survey: reliability and validity in a patient population. Med. Care. 1988;26:724–735
  71. Strakowski SM, DelBello MP. The impact of substance abuse on the course of bipolar disorder. Biol. Psychiatry. 2000;48:477–485
  72. Strakowski SM, Sax KW. Course of psychiatric and substance abuse syndromes co-occurring with bipolar disorder after a first psychiatric hospitalization. J. Clin. Psychiatry. 1998;59:465–471
  73. Strakowski SM, Tohen M. Comorbidity in mania at first hospitalization. Am. J. Psychiatry. 1992;149:554–556
  74. Suppes T, Leverich GS, Keck PE, Nolen WA, Denicoff KD, Altshuler LL, et al. The Stanley Foundation Bipolar Treatment Outcome Network: 11 demographics and illness characteristics of the first 261 patients. J. Affect Disord. 2001;67:45–59
  75. Swann AC, Stokes PE, Casper R, Secunda SK, Bowden CL, Berman N, et al. Hypothalamic–pituitary–adrenocortical function in mixed and pure mania. Acta Psychiatr. Scand. 1992;85:270–274
  76. Szadoczky E. The prevalence of major depressive and bipolar disorders in Hungary. Results from a national epidemiologic survey. J. Affect Disord. 1998;50:153–162
  77. Tamam L, Ozpoyraz N. Comorbidity of anxiety disorder among patients with bipolar I disorder in remission. Pychopathology. 2002;35:203–209
  78. Tsai SY, Chen CC. Alcohol problems and long-term psychosocial outcome in Chinese patients with bipolar disorder. J. Affect Disord. 1997;46:143–150
  79. Van Gorp WG, Altshuler L, Theberge DC, Wilkins J, Dixon W. Cognitive impairment in euthymic bipolar patients with and without prior alcohol dependence. A preliminary study. Arch. Gen. Psychiatry. 1998;55:41–46
  80. Vieta E, Colom F, Corbella B, Martinez-Aran A, Reinares M, Benabarre A, et al. Clinical correlates of psychiatric comorbidity in bipolar I patients. Bipolar Disord. 2001;3:253–258
  81. Weiss RD, Griffin ML, Greenfield SF, Najavits LM, Wyner D, Soto JA, et al. Group therapy for patients with bipolar disorder and substance dependence: results of a pilot study. J. Clin. Psychiatry. 2000;61:361–367
  82. Winokur G, Coryell W. Alcoholism in manic–depressive (bipolar) illness: familial illness, course of illness, and the primary–secondary distinction. Am. J. Psychiatry. 1995;152:365–372
  83. Winokur G, Cook B, Liskow B, Fowler R. Alcoholism in manic depressive (bipolar) patients. J. Stud. Alcohol. 1993;54:574–576
  84. Winokur G, Turvey C, Akiskal H, Coryell W, Solomon D, Leon A, et al. Alcoholism and drug abuse in three groups—bipolar I, unipolars and their acquaintances. J. Affect Disord. 1998;50:81–89

PII: S0165-0327(04)00437-9

doi: 10.1016/j.jad.2004.11.009

Journal of Affective Disorders
Volume 85, Issue 3 , Pages 301-315 , April 2005